NASDAQ · Medical - Diagnostics & Research

GRAL (GRAL) Stock

$63.44 -1.52% NASDAQ: GRAL Healthcare

Valuation

MetricValue
Price$63.44
Market Cap$2.72B
P/E Ratio-5.46
P/B Ratio1.01
P/S Ratio16.53
EPS (TTM)$-11.11
52-Week High$118.84
52-Week Low$29.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.83%
ROA-13.96%
ROCE-20.71%
Gross Margin-363.27%
Operating Margin-363.27%
Net Margin-2.53%
Debt/Equity0.02
Current Ratio11.93

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.0M$56.0M$93.0M$126.0M$147.0M
Operating Profit$-1.3B$-5.4B$-1.5B$-2.2B$-534.0M
Net Profit$-1.2B$-5.4B$-1.5B$-2.0B$-408.0M
EPS$-40.18$-173.87$-47.20$-63.54$-11.11
Op Margin-8659.6%-9798.2%-1627.6%-1743.0%-362.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$9.7B$5.6B$4.6B$3.0B$2.9B
Total Liabilities$307.0M$956.0M$911.0M$480.0M$344.0M
Cash$221.0M$242.0M$97.0M$214.0M$250.0M
Borrowings$111.0M$96.0M$84.0M$68.0M$98.0M

Latest News

Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans PR Newswire · Jul 16, 2026 Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. Motley Fool · Jul 13, 2026 Prediction: Grail Stock Will Skyrocket to $100 in 1 Year Motley Fool · Jul 2, 2026 GRAIL Completes $110 Million Equity Financing With Samsung Entities PR Newswire · Jun 25, 2026 A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors. Motley Fool · Jun 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-688.0M$-561.0M$-596.0M$-577.0M$-299.0M
Investing Cash Flow$275.0M$-46.0M$-26.0M$-556.0M$-86.0M
Financing Cash Flow$389.0M$605.0M$464.0M$1.2B$0
Net Cash Flow$-143.0M$20.0M$-145.0M$116.0M$39.0M
Free Cash Flow$-758.0M$-584.0M$-609.0M$-582.0M$-299.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-11.29%
Quick Ratio11.74
Interest Coverage—
Return 1Y90.04%
Return 3Y—
Return 5Y—

Ownership

Insiders Held5.23%
Institutions Held83.49%
Institutions Float Held88.09%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP4,028,6142026-03-31
Farallon Capital Management LLC3,253,6842026-03-31
Blackrock Inc.2,968,5362026-03-31
State Street Corporation1,891,8932026-03-31
Primecap Management Company1,843,7722026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About GRAL

GRAL stock trades at $63.44 with a market capitalization of $2.72B. The stock is valued at a price-to-earnings (P/E) ratio of -5.46, price-to-book of 1.01, price-to-sales of 16.53. Over the past 52 weeks the stock has ranged between $29.95 and $118.84, and currently trades 46.6% below its 52-week high.

On profitability, GRAL generates a return on equity (ROE) of -15.83%, return on capital employed of -20.71%, an operating margin of -363.27%, a net profit margin of -2.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides